Abstract: The study found that the mortality rate of patients treated with the traditional Chinese medicine “Qingfei Paidu Decoction” was about 1.2%, while the mortality rate of patients who did not use this traditional Chinese medicine was about 4.8%.
According to a report on the website of Hong Kong’s “South China Morning Post” on the 3rd, a WHO expert panel recommended that member states consider using traditional Chinese medicine to help control the new crown epidemic. They say there is evidence that Chinese medicine can be beneficial in some cases.
The report comes after a three-day meeting from late February to early March this year, the report said. The report explores the value of using traditional Chinese medicine to treat COVID-19.
Experts believe that traditional Chinese medicine can help reduce the risk of mild and common new coronary pneumonia developing into severe disease. They say that although the trial settings vary, the data suggest that TCM is safe and beneficial when used in combination with conventional antiviral drugs.
The group also recommended further analysis and trials, and the results shared with member states, the report noted.
According to the report, 21 international experts attended the meeting, including representatives of WHO and members of the Chinese Academy of Chinese Medical Sciences. Yu Wenming, director of the State Administration of Traditional Chinese Medicine, said at the meeting that several traditional Chinese medicines and therapies for the treatment of new coronary pneumonia are currently being optimized to deal with new mutant strains; the use of traditional Chinese medicine is one of the keys to maintaining a low rate of relapse in China.
Rudy Eggers, Director of WHO’s Department of Integrated Health Services, said that the WHO considers traditional and complementary medicine to be critical and that it was one of the most downloaded topics from the WHO website over the past year. one.
According to the report, some traditional remedies have been included in the national new coronary pneumonia diagnosis and treatment plan. This includes Lianhua Qingwen Capsules. Chinese researchers mentioned the trial on 284 patients at a relevant WHO meeting. Studies have shown that patients who take the proprietary Chinese medicine recover faster than those who do not take the traditional Chinese medicine intervention. A TCM expert said the capsules help to clear viruses, strengthen the lungs and reduce fever.
Li Guangxi, director of the respiratory department at Guang’anmen Hospital of the Chinese Academy of Chinese Medical Sciences, said the goal of traditional Chinese medicine is to strengthen the immune system before an infection occurs, and in severe cases, aid recovery by reducing sepsis and emotional disturbances.
He said that clinical trials have shown that for patients with mild and common new coronary pneumonia, traditional Chinese medicine shortens the time it takes to eliminate symptoms and clear the virus, and reduces the proportion of patients who develop severe disease. For critically ill and critically ill patients, a two-pronged approach of conventional medicine and traditional Chinese medicine treatment shortens the time spent in intensive care and mechanical ventilation.
Chinese scientists also cited the results of a study of nearly 9,000 hospitalized COVID-19 patients, the report pointed out. The study found that the mortality rate of patients treated with the traditional Chinese medicine “Qingfei Paidu Decoction” was about 1.2%, while the mortality rate of patients who did not use the traditional Chinese medicine treatment was about 4.8%. Scientists believe this prescription is associated with a substantial reduction in hospital mortality.
According to Hong Kong’s “Ta Kung Pao” report on April 4, proprietary Chinese medicines played an active role in the fifth wave of the epidemic in Hong Kong. The “Hong Kong Integrative Chinese and Western Medicine Anti-epidemic Alliance” conducted data collection in a residential care home for the elderly and found that after taking “Jinhua Qinggan Granules”, none of the infected elders developed severe symptoms, and symptoms such as fever and sore throat also improved. Alliance founder and Legislative Council member Lim Shun-chao hopes the government will better integrate Chinese and Western medicine to treat elderly patients.
According to the report, an outbreak of the epidemic began in the elderly care homes participating in the survey in late February. There were a total of 86 people in the homes, 8 of whom were sent to the hospital, and most of the remaining people contracted the disease one after another. 75 people later took “Jinhua Qinggan Granules”, of which 6 people were free of infection, and the 69 people who were infected did not have severe disease or adverse reactions after taking the medicine. Their average age was about 81 years old. After three weeks of nucleic acid testing, three-quarters of the people have recovered, and the other quarter has only a low viral load. The three residents who were unwilling to take the medicine were all seriously ill and sent to the hospital, and two died in the end.
Lin Shunchao pointed out that most of the residents have only received one shot of the vaccine, and the time between infection and vaccination is very short, so basically there is no vaccine protection. He believes that the combination of vaccines and proprietary Chinese medicines is bound to produce better epidemic prevention effects.
Editor in charge: Wu Zhengdan
32382344,. WHO experts believe: Chinese medicine is safe and beneficial to help treat the new crown,. 2022-04-06 09:46:42,. 204064,. Wu Zhengdan